Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Gastrointestinal Bleeding Treatment Market Size, Share & Trends Analysis: Global Industry Size Is Predicted to Grow USD 1092 Million by 2030, at a CAGR of likely 4.56%

This image opens in the lightbox

News provided by

FnF Research

28 Apr, 2023, 15:15 GMT

Share this article

Share toX

Share this article

Share toX

NEW YORK, April 28, 2023 /PRNewswire/ -- As per Facts and Factors study, the global gastrointestinal bleeding treatment market size was worth around USD 732 million in 2021 and is predicted to grow to around USD 1092 million by 2030 with a compound annual growth rate (CAGR) of roughly 4.56% between 2022 and 2030.

Report Link with All Related Graphs & Charts: https://www.fnfresearch.com/gastrointestinal-bleeding-treatment-market

Gastrointestinal Bleeding Treatment Market: Overview

Gastrointestinal bleeding is a symptom associated with digestive tract disorder. The blood, as a consequence of the condition, generally appears in vomit or stool but it may not be visible when appearing with the latter as the stool color may change to tarry or black. The blood flow intensity can vary from mild to severe and in certain cases, it is life-threatening. To effectively locate the bleeding cause, sophisticated imaging tools are required and the treatment will depend on the bleeding source. The signs of the condition can either be hidden or obvious and they are dependent on the exact location the bleeding is occurring from.

Obvious bleeding is called overt bleeding and it may show up as vomit blood that is generally dark brown or red. It may also be as black or tarry stool or in the form of rectal bleeding. In the case of hidden bleeding, called occult bleeding, the associated symptoms include chest pain, difficulty in breathing, lightheadedness, fainting, and abdominal pain. A patient suffering from gastrointestinal (GI) bleeding may go into shock if the bleeding starts suddenly or the rate of flow increases abruptly. There are certain symptoms that are related to shock and include rapid pulse, drop in blood pressure, and unconsciousness amongst others.

Get a Free Sample Report with All Related Graphs & Charts (with COVID 19 Impact Analysis): https://www.fnfresearch.com/sample/gastrointestinal-bleeding-treatment-market

Key Insights:

  • As per the analysis shared by our research analyst, the global gastrointestinal bleeding treatment market is estimated to grow annually at a CAGR of around 4.56% over the forecast period (2022-2030)
  • In terms of revenue, the global gastrointestinal bleeding treatment market size was valued at around USD 732 million in 2021 and is projected to reach USD 1092 million, by 2030.
  • The market is projected to grow at a significant rate due to the growing population suffering from GI bleeding-inducing diseases
  • Based on gastrointestinal (GI) tract division segmentation, upper GI was predicted to show maximum market share in the year 2021
  • Based on product segmentation, endoscopic hemostatic devices were the leading product in 2021
  • On the basis of region, North America was the leading revenue generator in 2021

Facts and Factors published the latest report titled "Gastrointestinal Bleeding Treatment Market Size, Share, Growth Analysis Report By Gastrointestinal (GI) Tract Division (Lower GI and Upper GI), By Product (Closure Devices and Endoscopic Hemostatic Devices), and By Region - Global and Regional Industry Insights, Overview, Comprehensive Analysis, Trends, Statistical Research, Market Intelligence, Historical Data and Forecast 2022 – 2030" into their research database.

Industry Dynamics:

Global Gastrointestinal Bleeding Treatment Market: Growth Drivers

  • Growing population suffering from GI bleeding-inducing diseases to propel market demand.

The global gastrointestinal bleeding treatment market is projected to grow owing to the increasing number of patients who are suffering from diseases that can cause GI bleeding. GI is not a disease in itself but one of the symptoms associated with several diseases. Some of them include ulcerative colitis, peptic ulcers, hemorrhoids, inflammation of the esophagus, colon, stomach, or esophagus cancer, and Crohn's disease. As the cause of GI bleeding can be any of the mentioned diseases, the number of patients with the issue remains consistently high.

Crohn's disease remains one of the leading causes of gastrointestinal bleeding. It is an inflammatory bowel disease (IBD) that leads to swelling of the digestive tract tissue. It can cause weight loss leading up to malnutrition or severe abdominal pain. In certain situations, Crohn's disease can be life-threatening. Currently, there is no cure for the disease but therapies can help patients manage the condition and symptoms. With enough and effective treatment, many patients have reported being functional well. As per official data, upper GI bleeding is observed in almost 50 to 150 out of 100,00 adults annually. More than 100,000 people in the US reportedly visit hospitals to get GI bleeding treatment. 

Global Gastrointestinal Bleeding Treatment Market: Restraints

  • Uncertainty related to the cause of the disease to impede market expansion.

There is no one particular reason for GI bleeding to start. It can due to several factors which make the detection of the symptom extremely difficult in the medical community. Doctors and healthcare professionals have to invest in highly advanced imaging techniques to understand the main reason for the bleeding to occur which results in delayed treatment. Without the right information, doctors are unable to provide an accurate and timely cure.

Directly Purchase a Copy of the Report @ https://www.fnfresearch.com/buynow/su/gastrointestinal-bleeding-treatment-market

Gastrointestinal Bleeding Treatment Market: Opportunity

  • Increasing cases of stomach cancer to cause further growth.

One of the most common symptoms of a stomach or gastric cancer is gastrointestinal bleeding. In the majority of the cases, occult bleeding is more common as compared to overt bleeding which is observed in less than 20% of the cases. Stomach cancer occurs due to the cells that originate in the stomach. Gastric cancer may not necessarily show any initial symptoms but patients in the later stages of cancer are known to suffer from extreme weight loss, tiredness, black stools, and vomiting blood. Studies have indicated that over 7 in 100,000 people get diagnosed with stomach cancer and 0.8% of men & women may be diagnosed with the disease at some point in life.

Gastrointestinal Bleeding Treatment Market: Challenges

  • Clearing of the blood clot and blood remains a challenge in the market.

The biggest challenge that remains during the medical procedures involving the operation related to upper GI bleeding is the proper clearing of blood clots and blood to help the medical professionals clearly visualize the bleeding site. Gastric lavage is the most widely used method but it is an extremely lengthy process and sometimes it may not remove the gastric content completely.

Global Gastrointestinal Bleeding Treatment Market: Segmentation

  • The global gastrointestinal bleeding treatment market is segmented based on gastrointestinal (GI) tract division, product, and region.

Based on the gastrointestinal (GI) tract division, the global market segments are lower GI and upper GI with the latter leading the segmental growth in 2021 due to the high prevalence of the condition. One of the major reasons for upper GI tract bleeding is peptic ulcer. These are sores that originate in the inner lining of the stomach along with the upper portion of the small intestine. The sores can be caused due to stomach lining getting damaged because of stomach acid, consumption of anti-inflammatory drugs, or bacteria. The chances of a person suffering from upper GI bleeding is 70% whereas the risk percentage for lower GI bleeding is around 30%.

Based on product, the global market divisions are closure devices and endoscopic hemostatic devices with the latter leading the global market growth in the previous year and the same trend projected for the coming years. Endoscopic hemostatic is one of the most common methods of treating gastrointestinal bleeding. The procedure is critical for managing GI hemorrhage and for preventing GI bleeding during highly risky endoscopic processes. A recent study concluded the success rate of endoscopic treatment for treating peptic ulcers was around 94%.

Get More Insight before Buying@: https://www.fnfresearch.com/inquiry/gastrointestinal-bleeding-treatment-market

List of Key Players in Gastrointestinal Bleeding Treatment Market:

  • Ovesco Endoscopy AG.
  • CONMED Corporation
  • Cook Medical
  • Boston Scientific Corporation
  • Olympus Corporation
  • US Medical Innovations

Key questions answered in this report:

  • What are the growth rate forecast and market size for GASTROINTESTINAL BLEEDING TREATMENT Market?
  • What are the key driving factors propelling the GASTROINTESTINAL BLEEDING TREATMENT Market forward?
  • What are the most important companies in the GASTROINTESTINAL BLEEDING TREATMENT Market Industry?
  • What segments does the GASTROINTESTINAL BLEEDING TREATMENT Market cover?
  • How can I receive a free copy of the GASTROINTESTINAL BLEEDING TREATMENT Market sample report and company profiles?

Report Scope:

Report Attribute

Details

Market size value in 2021

USD 732 Million

Revenue forecast in 2030

USD 1,092 Million

Growth Rate

CAGR of almost 4.56 % 2023-2030

Base Year

2020

Historic Years

2016 – 2022

Forecast Years

2022 – 2030

Segments Covered

By Gastrointestinal (GI) Tract Division, Product, and Region

Forecast Units

Value (USD Billion), and Volume (Units)

Quantitative Units

Revenue in USD million/billion and CAGR from 2022 to 2030

Regions Covered

North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World

Countries Covered

U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others

Companies Covered

Ovesco Endoscopy AG., CONMED Corporation, Cook Medical, Boston Scientific Corporation, Olympus Corporation, US Medical Innovations, and others.

Report Coverage

Market growth drivers, restraints, opportunities, Porter's five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.

Customization Scope

Avail of customized purchase options to meet your exact research needs.  

https://www.fnfresearch.com/customization/gastrointestinal-bleeding-treatment-market

 Free Brochure: https://www.fnfresearch.com/ask-to-analyst/gastrointestinal-bleeding-treatment-market

Regional Dominance:

  • North America to register the highest growth.

The global gastrointestinal bleeding treatment market is projected to register the highest growth in North America due to the highly advanced medical infrastructure of the US and Canada. The regional growth is likely to witness surging growth due to the rise in approvals by the US Food and Drugs Administration (FDA) authority. In 2018, the agency approved the use of a Hemospray device which is meant to treat GI bleeding conditions. The device is capable of stopping the bleeding without the use of any mechanical, thermal, or contact method that is known to cause complications if not done correctly.

Hemospray is a single-use device and it works by spraying inorganic power on the bleeding site which becomes an advantageous factor because it eliminates the need to visualize the site. Growth in Asia-Pacific may be driven by the increase in research & development of new treatment methods for GI bleeding-inducing medical diseases.

Global Gastrointestinal Bleeding Treatment Market is segmented as follows:

Gastrointestinal Bleeding Treatment Market: By Gastrointestinal (GI) Tract Division Outlook (2023-2030)

  • Lower GI
  • Upper GI

Gastrointestinal Bleeding Treatment Market: By Product Outlook (2023-2030)

  • Closure Devices
  • Endoscopic Hemostatic Devices

Gastrointestinal Bleeding Treatment Market: By Region Outlook (2023-2030)

North America

  • The U.S.
  • Canada

Europe

  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Mexico
  • Rest of Latin America

Middle East & Africa

  • GCC
  • South Africa
  • Rest of Middle East & Africa

Press Release: https://www.fnfresearch.com/news/global-gastrointestinal-bleeding-treatment-market

Browse Other Related Research Reports from Facts and Factors

  • Active Wound Care Market: According to the report published by Facts and Factors, the global active wound care market size was worth around USD 9.35 billion in 2022 and is predicted to grow to around USD 14.2 billion by 2030 with a compound annual growth rate (CAGR) of roughly 5.61% between 2023 and 2030.
  • MRI Contrast Media Agents Market: According to the report published by Facts and Factors, the global MRI contrast media agents market size was worth around USD 2.0 billion in 2022 and is predicted to grow to around USD 3.2 billion by 2030 with a compound annual growth rate (CAGR) of roughly 6.1% between 2023 and 2030.
  • Blood Clot Retrieval Devices Market: According to the report published by Facts and Factors, the global blood clot retrieval devices market size was worth around USD 1.6 billion in 2022 and is predicted to grow to around USD 5.0 billion by 2030 with a compound annual growth rate (CAGR) of roughly 15.2% between 2023 and 2030.
  • Respiratory Diagnostics Market: According to the report published by Facts and Factors, the global respiratory diagnostics market size was worth around USD 8.21 billion in 2021 and is predicted to grow to around USD 13.81 billion by 2030 with a compound annual growth rate (CAGR) of roughly 9.12% between 2022 and 2030.
  • Orthopedic Prosthetic Market: According to the report published by Facts & Factors, the global orthopedic prosthetic market size was worth around USD 2.3 billion in 2022 and is predicted to grow to around USD 3.4 billion by 2030 with a compound annual growth rate (CAGR) of roughly 5.31% between 2023 and 2030.

Browse through Facts and Factors's coverage of the Global Healthcare Industry

Follow Us on: LinkedIn | Twitter | Facebook

About Us

Facts and Factors is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, and company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client's needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:

Facts and Factors
Tel: +1 347 690-0211
USA/Canada Toll-Free No. +44 2032 894158
Email: sales@fnfresearch.com
Website: https://www.fnfresearch.com/

Logo: https://mma.prnewswire.com/media/1981423/FnF_Research_Logo.jpg

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.